| abstract |
The invention relates to bicyclic heteroaromatic compounds of formula or salts or solvates thereof. In the formula, the substituents have the meanings given in the description. The invention also relates to methods for the preparation of the compounds, to pharmaceutical compositions containing them, to their use in medicine, and to the preparation of medicaments for the treatment of disorders mediated by c-erbB-2 and / or EGF-R protein tyrosine kinase activity, in particular cancer, malignant tumors and psoriasis. |